BioHorizons, Inc., subsidiary of Henry Schein, Inc. (HSIC), recently launched the MinerOss X – a family of xenograft products. This particular family of xenograft products is meant to be used in dental implant site development procedures.
BioHorizons' MinerOss X refers to an anorganic bovine bone mineral matrix that is physically and chemically comparable to the mineral structure of human bone, and has been designed for predictable regeneration of bones. This line of products will make available an exhaustive portfolio of regenerative hard and soft tissue grafting products to dentists.
Significantly, MinerOss X will complement the company's already successful product line of MinerOss allografts – which, till now, had been offering hard tissue grafting solutions only.
The MinerOss X family of xenografts comprises cancellous or cortical particulate, a moldable collagen block, and a cancellous particulate pre-loaded into a delivery syringe to assist optimal placement. These can be used in a variety of grafting applications like extraction socket grafting, ridge and sinus augmentation, grafting for implant placement and in the treatment of infrabony periodontal defects.
MinerOss X particulates and collagen are available in different sizes to facilitate both large and small grafting procedures, thereby supporting a wide range of regenerative operations.
BioHorizons became a majority-owned subsidiary of Henry Schein, a leading healthcare provider to office-based practices, in December last year when the latter took over 60% equity stake in the Alabama-based oral reconstructive device company.
BioHorizons delivered an impressive performance in the last reported second quarter of 2014 and management expects it to elevate the company's position in the overall prosthetics market.
We believe the launch of the MinerOss X family of xenografts products by BioHorizons will buoy Henry Schein's profitability further in the global implant market.
Currently, Henry Schein holds a Zacks Rank #2 (Buy). Other well-placed stocks in the med/dental-supply industry include The Cooper Companies Inc. (COO), Cardinal Health, Inc. (CAH) and DENTSPLY International Inc. (XRAY). While The Cooper Companies sports a Zacks Rank #1 (Strong Buy), both Cardinal Health and DENTSPLY International hold the same Zacks Rank as Henry Schein.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment